Cellontech

CELLONTECH, founded in 2000, is a research and development-focused biotechnology company that holds a leading position in technology and market share in the field of regenerative medicine both in China and internationally. Based on the concept of "achieving regenerative medicine beyond therapeutic medicine," CELLONTECH is committed to advancing the progress of regenerative medicine. As a pioneer in South Korea's regenerative medicine sector, CELLONTECH developed the first cell therapy in the country. The company’s R&D efforts primarily focus on regenerative therapies, cosmetic treatments, and treatments for blood and immune diseases in areas such as joints, cartilage, bones, connective tissues (ligaments-tendons), and skin. Utilizing the fundamental elements of "cells" and "biomaterials" that constitute human tissue, CELLONTECH has successfully commercialized various advanced regenerative medical products with its self-developed bio-collagen material at the core.